Skip to main content

ScienceDex / Researcher record

Gautam Dantas

From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.

FY2026 NIH rank #1,281
  • Program Leader
  • R01 Holder
  • Top 10% Funded
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2026

$8M
Full award amounts, FY2026
6
Records listing this PI
#1,281
By linked amount among FY2026 PIs
2024
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2024$3,707,6585#1,830
2025$3,450,4275#2,669
2026$8,003,6516#1,281

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20245 records
  2. FY20255 records
  3. FY2026 · selected6 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Gautam Dantas. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

NIAID

National Institute of Allergy and Infectious Diseases

$4.8M

5 awards · administering

OD

NIH Office of the Director

$3.2M

1 awards · funding

NCCIH

National Center for Complementary and Integrative Health

$0

1 awards · administering

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10254469Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pathology
  • Internal Medicine

FY2026 award records by amount

NIH award records listing Gautam Dantas as a PI. Multi-PI records show the full award amount for context.

  • 4U01AT012998-03U01Contact PI
    Functional characterization of viral-bacterial-human interactions during antimicrobial and inflammatory perturbations across different lifespans
    $3.2M
    award amount
  • 1P01AI197197-01P01Contact PI
    Multi-Omics Unit for Combating Antibiotic-Resistant Bacteria (MOCARB)
    $2.2M
    award amount
  • 1U01AI195139-01U01Co-investigator
    Phase 1b/2a Evaluation of the Safety and Tolerability of SYN-004 in Adult Allogeneic Hematopoietic Cell Transplantation (allo-HCT) Recipients
    $919.8K
    award amount
  • 5R01AI184858-03R01Contact PI
    High-resolution genomic interrogation of pathogen-microbiome interactions in Clostridioides difficile infection
    $767.3K
    award amount
  • 2R01AI155893-06R01Contact PI
    Impact of antibiotic and dietary perturbations on the functional maturation of the pediatric microbiome
    $738.5K
    award amount
  • 5R21AI188191-02R21Co-investigator
    Culturomic and metagenomic methods optimization to detect multi-strain C. difficile colonization and infection
    $194.4K
    award amount

Award organization

Organizations that administered FY2026 awards listing Gautam Dantas as a PI.

FY2026 award administered by Washington University in St. Louis (MO).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Washington University in St. Louis
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1830
  6. 2024
    Entered Top 25% Nationally
    Ranked #1830
  7. 2024
    Entered Top 10% Nationally
    Ranked #1830
  8. 2025
    $5M Cumulative Funding
  9. 2025
    R01 Grant Holder
  10. 2025
    Program/Center Grant Leader
  11. 2026
    $10M Cumulative Funding